Thompson Simon J, Loftus Liam T, Ashley Michelle D, Meller Robert
RS Dow Neurobiology Laboratories, Legacy Clinical Research and Technology Center, 1225 Ne 2nd Avenue, Portland, OR 97232, USA.
Curr Opin Pharmacol. 2008 Feb;8(1):90-5. doi: 10.1016/j.coph.2007.09.010. Epub 2007 Nov 5.
The ubiquitin-proteasome system is the major non-lysosymal system for degrading proteins in the cell; the work leading to its discovery was awarded the Nobel Prize in Chemistry in 2004. In addition to small ubiquitin-like modifiers (e.g. Sumo and Nedd8), ubiquitin is involved in the complex regulation of the levels and function of many proteins and signaling pathways involved in determining cell fate. The cell death regulatory proteins, such as Bcl-2 family proteins and caspases are targeted for degradation by the ubiquitin proteasome system (UPS). In addition to mediating the degradation of proteins, the UPS regulates function and translocation of proteins, many of which play a role in the determination of cell fate. For example the UPS can regulate the activity of transcription factors, such as P53, NF-kappaB and HIF-1 alpha, which control the expression of protein mediators of cell death. Aberrant UPS function has been reported in multiple neuropathologies including Parkinson's diseases and ischemia. With the number of ubiquitin conjugating and de-conjugating enzymes reaching close to the levels of protein kinases and phosphatases, it is clear that ubiquitination is an important biological regulatory step for proteins.
泛素-蛋白酶体系统是细胞内蛋白质降解的主要非溶酶体系统;导致其发现的研究成果于2004年被授予诺贝尔化学奖。除了小泛素样修饰物(如Sumo和Nedd8)外,泛素还参与许多蛋白质水平和功能以及决定细胞命运的信号通路的复杂调控。细胞死亡调节蛋白,如Bcl-2家族蛋白和半胱天冬酶,是泛素蛋白酶体系统(UPS)的降解靶点。除了介导蛋白质降解外,UPS还调节蛋白质的功能和转运,其中许多蛋白质在决定细胞命运中发挥作用。例如,UPS可以调节转录因子的活性,如P53、核因子κB和缺氧诱导因子-1α,它们控制细胞死亡蛋白介质的表达。在包括帕金森病和局部缺血在内的多种神经病理学中都报道了UPS功能异常。随着泛素缀合和去缀合酶的数量接近蛋白激酶和磷酸酶的水平,很明显泛素化是蛋白质重要的生物调节步骤。